Chiara Cilibrasi
Brighton, ENG BN19QG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.
Journal: International journal of molecular sciences
Published: September 22, 2022
Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer.
Journal: Brain, behavior, and immunity
Published: June 10, 2022
PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38MAPK signalling.
Journal: Oncogene
Published: February 03, 2022
Tuneable synthetic reduced graphene oxide scaffolds elicit high levels of three-dimensional glioblastoma interconnectivity in vitro.
Journal: Journal of materials chemistry. B
Published: December 21, 2021
Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment.
Journal: Biomolecules
Published: December 14, 2021
Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies.
Journal: International journal of molecular sciences
Published: October 14, 2021
Correction to: LMTK3 inhibition affects microtubule Stability.
Journal: Molecular cancer
Published: April 10, 2021
Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.
Journal: International journal of molecular sciences
Published: December 21, 2020
The structure-function relationship of oncogenic LMTK3.
Journal: Science advances
Published: April 26, 2020
EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
Journal: Endocrine connections
Published: April 15, 2019
Last Updated: 09/26/2026